July 6, 2018 by Deborah Wormser, UT Southwestern Medical Center
A DNA-sensing enzyme forms droplets that act as tiny bioreactors creating molecules to stimulate innate immunity—the body’s first response to infection, UT Southwestern researchers report. The work, reported today in the journal Science, could lead to novel treatments for infections, autoimmune disease, and cancer.
Leave a Reply